Sort by
Refine Your Search
-
well as on the development of novel peptide-based therapeutic concepts. The research group is led by Professor Artur Schmidtchen. The group consists of approximately seven members, including senior researchers, PhD students
-
studies ranging from the development and preclinical evaluation of radiopharmaceuticals to biological characterization, quantitative image analysis, and assessment of treatment response. Within the research
-
precision medicine by improving prognostication and treatment selection for cancer patients through the development of novel prognostic and treatment-predictive biomarkers, as well as by elucidating tumor
-
to the project's theory development on decentralization and modularity in socio-technical systems, especially in the project's initial phase plan and carry out empirical work – document studies, interviews and
-
, or other forms of public engagement. Contribute actively to the development of the HEIRS research node and its activities. Contribute to the development of new research grant applications associated with